Palliation of cancer patients in terminal care

Part of the Collection de L’Académie Européenne de Médecine de Réadaptation book series (LACADEMIE)


Terminal care refers to the care of the dying patient in the last hours or days of life. Principles of care in terminal care are symptom control, avoidance of unnecessary interventions, a regular control of drugs and symptoms, continuity of regular communication, and support of relatives and carers. Clinical issues that commonly arise in the last hours of living include the management of feeding and hydration, changes in consciousness, delirium, pain, breathlessness, and secretions. All drugs necessary for symptom control must continuously be given in the terminal phase.


Palliative Care Terminal Phase Pastoral Care Professional Caregiver Terminal Care 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. — Bausewein C, Fegg M, Radbruch L et al. (2005) Validation and clinical application of the German version of the palliative care outcome. J Pain Symptom Manage 30: 51–62PubMedCrossRefGoogle Scholar
  2. — Billings JA (1985) Comfort measures for the terminally ill: Is dehydration painful? J Am Geriatr Soc 33: 808–10PubMedGoogle Scholar
  3. — Bruera E, Fainsinger RL (1998) Clinical management of cachexia and anorexia. In: Doyle D, Hanks GWC, MacDonald N, eds. Oxford Textbook of Palliative Medicine. 2nd ed. Oxford, England: Oxford University Press; 548Google Scholar
  4. — Dudgeon D, Lertzmann M (1999) Dyspnea in the advanced cancer patient. J Pain Symptom Manage. 18,5: 313–5CrossRefGoogle Scholar
  5. — Feldman MD (1986) Paradoxical effects of benzodiazepines. NC Med J 47: 311–2Google Scholar
  6. — Lethen W (1993) Mouth and skin problems In: Saunders C, Sykes N. The Management of Terminal Malignant Disease, 3rd ed. Boston: Edward Arnold, 139–42Google Scholar
  7. — Levy MH, Cohen SD (2005) Sedation for the relief of refractory symptoms in the imminently dying: A fine intentional line. Semin Oncol 32: 237–46PubMedCrossRefGoogle Scholar
  8. — Ljubisavljevic V, Kelly B (2003) Risk factors for development of delirium among oncology patients. Gen Hosp Psychiatry 25: 345–52PubMedCrossRefGoogle Scholar
  9. — Storey P (1998) Symptom control in dying. In: Berger A, Portenoy RK, Weissman D, eds. Principles and Practice of Supportive Oncology Updates. Philadelphia, Pa: Lippincott-Raven Publishers, 741–8Google Scholar
  10. — Thomas J, von Gunten C (2003) Management of dyspnea. J Support Oncol. 1: 23–32PubMedGoogle Scholar
  11. — Twycross R, Lichter I (1998) The terminal phase. In: Doyle D, Hanks GWC, MacDonald N, eds. Oxford Textbook of Palliative Medicine. 2nd ed. Oxford, England: Oxford University Press, 985–6Google Scholar
  12. — Zaw-Tun N, Bruera E (1992) Active metabolites of morphine. J Palliat Care 8: 48–50PubMedGoogle Scholar

Copyright information

© Springer-Verlag France, Paris 2007

Personalised recommendations